Dr. Gina Jiang is the Managing Director of the Hong Kong Institute of Biotechnology and the Head of Technology Integration and Application at the Chinese University of Hong Kong, where she leads the establishment of the Advanced Therapy Products (ATP) GMP Centre, the modernisation of Proprietary Chinese Medicine (pCM) manufacturing, the expansion of the institute’s GMP capabilities and capacities, and trainings of GMP talents.

A medical entrepreneur that sits at the intersection of medicine, design, and technology, Dr. Jiang has built a number of med tech startups in Silicon Valley and Taipei, including FGMi, Inc., which focuses on analysing patients’ clinical needs and overall patient journeys to accelerate beachside researches to bedside applications.